Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 158

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 158
---
and from time to time during the term of the Convertible Notes. Under the applicable Nasdaq rules, in no event may we issue to
Yorkville under the SEPA or otherwise, including under conversion of the Convertible Notes, collectively more than 6,855,459 shares
of Common Stock, which number of shares is equal to 19.99% of the shares of Common Stock outstanding immediately prior to the
execution of the SEPA (the “Exchange Cap”), unless we receive the requisite stockholder approval to issue shares of
Common Stock in excess thereof in accordance with applicable Nasdaq rules.

Under
the SEPA, we also have the right to sell to Yorkville an additional $14.0 million of our Common Stock in the form of one or more advances
(the “Advances”), subject to certain limitations and conditions. Sales of our shares of Common Stock to Yorkville as Advances
under the SEPA, and the timing of any such sales, are at our complete discretion and we are under no obligation to sell any shares of
Common Stock to Yorkville under the SEPA.

The
price of our Common Stock could decline if there are substantial sales of shares of our Common Stock, if there is a large number of shares
of our Common Stock available for sale, or if there is the perception that these sales could occur.

Any
issuance of shares of Common Stock pursuant to the SEPA, if not terminated and if and when available, whether upon conversion by Yorkville
of a Convertible Note or upon issuance of common shares in the form of an Advance, will dilute the percentage ownership of our stockholders
and may dilute the per share projected earnings (if any) or book value of our Common Stock. Sales of a substantial number of shares of
our Common Stock in the public market or other issuances of shares of our Common Stock, or the perception that these sales or issuances
could occur, could cause the market price of our Common Stock to decline and may make it more difficult for you to sell your shares at
a time and price that you deem appropriate.

The
actual number of shares of Common Stock we will issue pursuant to the SEPA, if not terminated and if and when available, at any one time
or in total, is uncertain.

Subject
to certain conditions in the SEPA, if not terminated and if and when available, and subject to compliance with applicable law, we have
issued Convertible Notes to Yorkville, which may be converted into